Erythrocyte Complement Receptor 1 and Alzheimer Disease

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2012 by CHU de Reims.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
CHU de Reims
ClinicalTrials.gov Identifier:
NCT01565434
First received: March 26, 2012
Last updated: March 27, 2012
Last verified: March 2012
  Purpose

Main objective: investigate whether a functional polymorphism of CR1 (length, number of binding sites in C4b C3b, erythrocyte density, rate of soluble CR1 ...) so determined genetic or acquired, is a susceptibility factor for the disease Alzheimer's.


Condition Intervention
Alzheimer Disease
Other: CR1 impact

Study Type: Interventional
Study Design: Primary Purpose: Screening

Resource links provided by NLM:


Further study details as provided by CHU de Reims:

Estimated Enrollment: 200
Study Start Date: February 2012
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • caucasians people with a Alzheimer dementia defined on DSMIV criteria for patients and without Alzheimer disease for control subjects

Exclusion Criteria:

  • diseases modifying CR1 physiology
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01565434

Contacts
Contact: Rachid MAHMOUDI, MD rmahmoudi@chu-reims.fr

Locations
France
CHU de REIMS Recruiting
Reims, France, 51092
Contact: Rachid MAHMOUDI, MD       rmahmoudi@chu-reims.fr   
Principal Investigator: Rachid MAHMOUDI, MD         
Sponsors and Collaborators
CHU de Reims
  More Information

No publications provided

Responsible Party: CHU de Reims
ClinicalTrials.gov Identifier: NCT01565434     History of Changes
Other Study ID Numbers: REIMS-AOL2011-01
Study First Received: March 26, 2012
Last Updated: March 27, 2012
Health Authority: France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Additional relevant MeSH terms:
Alzheimer Disease
Dementia
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Tauopathies
Neurodegenerative Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders

ClinicalTrials.gov processed this record on April 15, 2014